P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847108.51760.ea |
| _version_ | 1827336355503407104 |
|---|---|
| author | J. Mascarenhas A. T. Gerds J. K. Kish P. Abraham A. Balanean J. A. Nadal D. Liassou B. A. Feinberg A. McBride C. Harrison |
| author_facet | J. Mascarenhas A. T. Gerds J. K. Kish P. Abraham A. Balanean J. A. Nadal D. Liassou B. A. Feinberg A. McBride C. Harrison |
| author_sort | J. Mascarenhas |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:29:16Z |
| format | Article |
| id | doaj.art-b08d4f636a334bb78a8ec1a1b02e2c46 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:29:16Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-b08d4f636a334bb78a8ec1a1b02e2c462024-03-02T06:40:53ZengWileyHemaSphere2572-92412022-06-01695095110.1097/01.HS9.0000847108.51760.ea202206003-00950P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILUREJ. Mascarenhas0A. T. Gerds1J. K. Kish2P. Abraham3A. Balanean4J. A. Nadal5D. Liassou6B. A. Feinberg7A. McBride8C. Harrison91 The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York2 Cleveland Clinic Taussig Cancer Institute, Cleveland3 Cardinal Health, Dublin4 Bristol Myers Squibb, Princeton, United States of America3 Cardinal Health, Dublin4 Bristol Myers Squibb, Princeton, United States of America3 Cardinal Health, Dublin3 Cardinal Health, Dublin4 Bristol Myers Squibb, Princeton, United States of America5 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdomhttp://journals.lww.com/10.1097/01.HS9.0000847108.51760.ea |
| spellingShingle | J. Mascarenhas A. T. Gerds J. K. Kish P. Abraham A. Balanean J. A. Nadal D. Liassou B. A. Feinberg A. McBride C. Harrison P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE HemaSphere |
| title | P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE |
| title_full | P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE |
| title_fullStr | P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE |
| title_full_unstemmed | P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE |
| title_short | P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE |
| title_sort | p1060 real world clinical outcomes after 3 and 6 months of treatment with fedratinib following ruxolitinib failure |
| url | http://journals.lww.com/10.1097/01.HS9.0000847108.51760.ea |
| work_keys_str_mv | AT jmascarenhas p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT atgerds p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT jkkish p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT pabraham p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT abalanean p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT janadal p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT dliassou p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT bafeinberg p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT amcbride p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure AT charrison p1060realworldclinicaloutcomesafter3and6monthsoftreatmentwithfedratinibfollowingruxolitinibfailure |